Monica Wang
Company: Takeda Pharmaceuticals
Job title: Principal Technology Lead, Project and Program Management, Scientific Informatics
Seminars:
Chair’s Closing Remarks & End of Day One 6:00 pm
day: Day One
Immunogenicity & Antigenicity-Based T-Cell & Epitopes Identification for Design of Biologic Therapeutics 10:00 am
In silico analysis as an integrative approach for the assessment of immunogenicity in the pre-clinical phase In vitro validation study to offer predictive insights on immunogenicity of biotherapeutics Remaining challenges to offer better predictive insights to mitigate clinical immunogenicity risk of biotherapeuticsRead more
day: Day One
Opening Remarks from the Chair 9:20 am
day: Day One